Scott E. Monroe

2.8k total citations · 1 hit paper
46 papers, 2.3k citations indexed

About

Scott E. Monroe is a scholar working on Reproductive Medicine, Endocrinology, Diabetes and Metabolism and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Scott E. Monroe has authored 46 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Reproductive Medicine, 14 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Scott E. Monroe's work include Ovarian function and disorders (16 papers), Hypothalamic control of reproductive hormones (13 papers) and Growth Hormone and Insulin-like Growth Factors (8 papers). Scott E. Monroe is often cited by papers focused on Ovarian function and disorders (16 papers), Hypothalamic control of reproductive hormones (13 papers) and Growth Hormone and Insulin-like Growth Factors (8 papers). Scott E. Monroe collaborates with scholars based in United States and Japan. Scott E. Monroe's co-authors include A. REES MIDGLEY, G. D. Niswender, LEO E. REICHERT, Robert B. Jaffe, E. Knobil, Milan R. Henzl, Eldon D. Schriock, Lorna A. Marshall, Philip D. Darney and Albert F. Parlow and has published in prestigious journals such as Journal of Clinical Investigation, Annals of Internal Medicine and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Scott E. Monroe

46 papers receiving 2.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Radioimmunoassay for Rat Luteinizing Hormone with Antiovine LH Serum and Ovine LH-131I

1968 799 citations A. REES MIDGLEY, Scott E. Monroe et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Scott E. Monroe	1.4k	704	450	297	284	46	2.3k
E.J. Keogh	1.2k 0.8×	580 0.8×	321 0.7×	418 1.4×	294 1.0×	45	2.2k
Rosemary Leask	622 0.5×	195 0.3×	718 1.6×	258 0.9×	205 0.7×	39	1.7k
G. H. Zeilmaker	1.3k 0.9×	150 0.2×	1.1k 2.5×	382 1.3×	284 1.0×	105	2.2k
Masahiko Maegawa	386 0.3×	220 0.3×	242 0.5×	172 0.6×	194 0.7×	60	1.3k
Jon D. Hennebold	882 0.6×	264 0.4×	1.1k 2.5×	980 3.3×	499 1.8×	108	2.6k
D. M. de Kretser	1.4k 1.0×	508 0.7×	692 1.5×	799 2.7×	627 2.2×	54	2.4k
Michael Knecht	708 0.5×	414 0.6×	885 2.0×	587 2.0×	451 1.6×	58	2.3k
Albina Jablonka‐Shariff	537 0.4×	157 0.2×	667 1.5×	526 1.8×	225 0.8×	49	1.9k
David K. Pomerantz	339 0.2×	210 0.3×	113 0.3×	245 0.8×	174 0.6×	49	987
R. G. EDWARDS	657 0.5×	66 0.1×	721 1.6×	289 1.0×	196 0.7×	46	2.2k

Countries citing papers authored by Scott E. Monroe

Since Specialization

Citations

This map shows the geographic impact of Scott E. Monroe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott E. Monroe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott E. Monroe more than expected).

Fields of papers citing papers by Scott E. Monroe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott E. Monroe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott E. Monroe. The network helps show where Scott E. Monroe may publish in the future.

Co-authorship network of co-authors of Scott E. Monroe

This figure shows the co-authorship network connecting the top 25 collaborators of Scott E. Monroe. A scholar is included among the top collaborators of Scott E. Monroe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott E. Monroe. Scott E. Monroe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fujimoto, Victor Y., et al.. (1997). Dose-related suppression of serum luteinizing hormone in women by a potent new gonadotropin-releasing hormone antagonist (Ganirelix) administered by intranasal spray. Fertility and Sterility. 67(3). 469–473. 24 indexed citations

Nelson, Linda R., Victor Y. Fujimoto, Robert B. Jaffe, & Scott E. Monroe. (1995). Suppression of follicular phase pituitary-gonadal function by a potent new gonadotropin-releasing hormone antagonist with reduced histamine-releasing properties (ganirelix). Fertility and Sterility. 63(5). 963–969. 44 indexed citations

Holloway, Leah, et al.. (1995). Effects of a gonadotropin-releasing hormone agonist on the calcium-parathyroid axis and bone turnover in women with endometriosis. American Journal of Obstetrics and Gynecology. 173(3). 824–829. 6 indexed citations

Fluker, Margo R., Scott E. Monroe, Lorna A. Marshall, & Robert B. Jaffe. (1994). Contrasting effects of a gonadotropin-releasing hormone agonist and antagonist on the secretion of free α subunit. Fertility and Sterility. 61(3). 573–575. 7 indexed citations

Darney, Philip D., et al.. (1992). Evaluation of a 1-year levonorgestrel-releasing contraceptive implant: side effects, release rates, and biodegradability. Fertility and Sterility. 58(1). 137–143. 21 indexed citations

Fluker, Margo R., Lorna A. Marshall, Scott E. Monroe, & Robert B. Jaffe. (1991). Variable Ovarian Response to Gonadotropin-Releasing Hormone Antagonist-Induced Gonadotropin Deprivation during Different Phases of the Menstrual Cycle*. The Journal of Clinical Endocrinology & Metabolism. 72(4). 912–919. 40 indexed citations

Marshall, Lorna A., Margo R. Fluker, Robert B. Jaffe, & Scott E. Monroe. (1991). Inhibition of Follicular Development by a Potent Antagonistic Analog of Gonadotropin-Releasing Hormone (Detirelix)*. The Journal of Clinical Endocrinology & Metabolism. 72(4). 927–933. 18 indexed citations

Kratzer, Paul G., et al.. (1991). First‐trimester aneuploidy screening using serum human chorionic gonadotropin (hCG), free ahCG, and progesterone. Prenatal Diagnosis. 11(10). 751–763. 31 indexed citations

Darney, Philip D., et al.. (1989). Clinical evaluation of the Capronor contraceptive implant: Preliminary report. American Journal of Obstetrics and Gynecology. 160(5). 1292–1295. 96 indexed citations

10.

Mendel, Carl M., James T. Murai, Pentti K. Siiteri, Scott E. Monroe, & Masayasu Inoue. (1989). CONSERVATION OF FREE BUT NOT TOTAL OR NON-SEX-HORMONE-BINDING-GLOBULIN-BOUND TESTOSTERONE IN SERUM FROM NAGASE ANALBUMINEMIC RATS. Endocrinology. 124(6). 3128–3130. 14 indexed citations

11.

Martin, Mary C., Scott E. Monroe, Richard I. Weiner, & Robert B. Jaffe. (1988). Low-dose dopamine infusions do not ablate luteinizing hormone pulses in women. American Journal of Obstetrics and Gynecology. 159(4). 898–903. 5 indexed citations

12.

Blumenfeld, Zeev, et al.. (1988). Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: Assessment by magnetic resonance imaging. American Journal of Obstetrics and Gynecology. 158(4). 903–910. 72 indexed citations

13.

Benz, Christopher C., et al.. (1987). Chemoendocrine therapy with prolonged estrogen priming in advanced breast cancer: endocrine pharmacokinetics and toxicity.. PubMed. 71(3). 283–9. 9 indexed citations

14.

Schriock, Eldon D., Scott E. Monroe, Milan R. Henzl, & Robert B. Jaffe. (1985). Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin). Fertility and Sterility. 44(5). 583–588. 85 indexed citations

15.

Monroe, Scott E., Milan R. Henzl, Mary C. Martin, et al.. (1985). Ablation of folliculogenesis in women by a single dose of gonadotropin-releasing hormone agonist: significance of time in cycle. Fertility and Sterility. 43(3). 361–368. 24 indexed citations

16.

Martin, Mary C., Richard I. Weiner, Scott E. Monroe, et al.. (1984). Prolactin-Secreting Adenomas in Women. VII. Dopamine Regulation of Prolactin Secretion*. The Journal of Clinical Endocrinology & Metabolism. 59(3). 485–490. 13 indexed citations

17.

Nachtigall, Robert D., Scott E. Monroe, Charles B. Wilson, & Robert B. Jaffe. (1981). Prolactin-secreting pituitary adenomas in women. VI. Absence of demonstrable adenomas in patients with altered menstrual function and abnormal sellar polytomography.. PubMed. 140(3). 303–8. 9 indexed citations

18.

Monroe, Scott E., Robert B. Jaffe, & A. REES MIDGLEY. (1972). Regulation of Human Gonadotropins. XIII. Changes in Serum Gonadotropins in Menstruating Women in Response to Oophorectomy. The Journal of Clinical Endocrinology & Metabolism. 34(2). 420–422. 35 indexed citations

19.

Atkinson, Linda E., A. N. Bhattacharya, Scott E. Monroe, Donald J. Dierschke, & E. Knobil. (1970). Effects of Gonadectomy on Plasma LH Concentration in the Rhesus Monkey. Endocrinology. 87(5). 847–849. 34 indexed citations

20.

Monroe, Scott E., et al.. (1952). THE DEVELOPMENT OF GASTRIC CARCINOMA IN PERNICIOUS ANEMIA. Annals of Internal Medicine. 37(2). 338–343. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact